Details for New Drug Application (NDA): 065072
✉ Email this page to a colleague
The generic ingredient in CEFOTAXIME is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for 065072
Tradename: | CEFOTAXIME |
Applicant: | Hikma |
Ingredient: | cefotaxime sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065072
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFOTAXIME | cefotaxime sodium | INJECTABLE;INJECTION | 065072 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9930 | 0143-9930-10 | 10 VIAL in 1 PACKAGE (0143-9930-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9930-01) |
CEFOTAXIME | cefotaxime sodium | INJECTABLE;INJECTION | 065072 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9931 | 0143-9931-25 | 25 VIAL in 1 PACKAGE (0143-9931-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9931-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Nov 20, 2002 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Nov 20, 2002 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Nov 20, 2002 | TE: | RLD: | No |
Complete Access Available with Subscription